Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117214) titled 'Individual susceptibility of different uterine contraction inhibitors to the treatment of premature birth patients' on Jan. 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
preterm labor
Intervention:
Patients diagnosed with premature birth who were treated with Rituojun alone as Group A:NA
those who were treated with Atoxiban alone during the same period as Group B:NA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-25
Target Sample Size: Patients diagnosed with premature birth who ...